featured
EORTC Risk Model to Predict Progression in Patients With Non–Muscle Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Genitourinary Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
EORTC Risk Model to Predict Progression in Patients With Non–Muscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice?
Clin Genitourin Cancer 2016 Apr 01;14(2)176-182, WF Busato Júnior, GL Almeida, CA Ribas, JM Ribas Filho, O De CobelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.